# Bartomeu Massutí

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bartomeu-massuti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,860 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 57 |
| i10-index | 144 |
| Last Known Institution | Universitat de Miguel Hernández d'Elx |
| OpenAlex ID | https://openalex.org/A5013884017 |
| ORCID iD | https://orcid.org/0000-0002-6247-4493 |
| Works | 428 |

## Researcher papers

- [Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial](https://scholariq.org/papers/erlotinib-versus-standard-chemotherapy-as-first-line-treatment-for-european/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Universitat de Miguel Hernández d'Elx](https://scholariq.org/institutions/universitat-de-miguel-hernandez-d-elx/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.